⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL7153209 | 0.91 | — | — | |
| SCHEMBL21354 | 0.90 | LMNA (0.32) | — | |
| SCHEMBL9077033 | 0.88 | — | — | |
| SCHEMBL11509920 | 0.88 | LMNA (0.36) | — | |
| SCHEMBL3629812 | 0.88 | LMNA (0.36) | — | |
| SCHEMBL1758460 | 0.85 | — | — | |
| SCHEMBL7155668 | 0.85 | — | — | |
| SCHEMBL7152022 | 0.83 | — | — | |
| SCHEMBL18538812 | 0.83 | — | — | |
| SCHEMBL7153052 | 0.83 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 217 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2022102909-A1 | PLASMA ETCHING METHOD | 아주대학교산학협력단 | 2022-05-19 | — | — | WO | claimed |
| CN-111326798-A | Electrolyte for lithium secondary battery and lithium secondary battery comprising the same | 现代自动车株式会社 | 2020-06-23 | — | — | CN | claimed |
| US-20190027786-A1 | Electrolyte Solution for Secondary Batteries, and Secondary Battery | NEC CORPORATION (JP) | 2019-01-24 | — | — | US | claimed |
| US-20180108935-A1 | ELECTROLYTE SOLUTION FOR SECONDARY BATTERIES, AND SECONDARY BATTERY | NEC CORPORATION (JP) | 2018-04-19 | — | — | US | claimed |
| EP-1127935-B1 | FLUORINE-CONTAINING SURFACE TREATMENT COMPOSITION | DAIKIN IND LTD (JP) | 2009-12-16 | — | — | EP | claimed |
| WO-2009019219-A2 | METHODS OF USING A SOLVENT OR A FOAM BLOWING AGENT | Solvay (Société Anonyme) (BE) | 2009-02-12 | — | — | WO | claimed |
| EP-1037673-B1 | CHARGED LIPIDS AND USES FOR THE SAME | IMARX PHARMACEUTICAL CORP (US) | 2006-08-23 | — | — | EP | claimed |
| EP-1039834-B1 | OPTOACOUSTIC CONTRAST AGENTS AND METHODS FOR THEIR USE | IMARX PHARMACEUTICAL CORP (US) | 2005-09-28 | — | — | EP | claimed |
| US-6808720-B2 | DRUG DELIVERY; CONTRAST FOR MEDICAL DIAGNOSIS | IMARX THERAPEUTICS, INC. | 2004-10-26 | — | — | US | claimed |
| US-6548047-B1 | Using lecithin, cephalin filled with gases; scanning; medical diagnosis | BRISTOL-MYERS SQUIBB MEDICAL IMAGING, INC. | 2003-04-15 | — | — | US | claimed |
| US-6403056-B1 | ADMINISTERING AGENT; APPLYING ULTRASONIC FREQUENCY | IMARX THERAPEUTICS, INC. | 2002-06-11 | — | — | US | claimed |
| EP-1037673-A4 | CHARGED LIPIDS AND USES FOR THE SAME | IMARX PHARMACEUTICAL CORP (US) | 2002-05-02 | — | — | EP | claimed |
| EP-1039834-A4 | OPTOACOUSTIC CONTRAST AGENTS AND METHODS FOR THEIR USE | IMARX PHARMACEUTICAL CORP (US) | 2001-12-05 | — | — | EP | claimed |
| EP-1039834-A1 | OPTOACOUSTIC CONTRAST AGENTS AND METHODS FOR THEIR USE | IMARX PHARMACEUTICAL CORP. (US) | 2000-10-04 | — | — | EP | claimed |
| EP-1037673-A1 | CHARGED LIPIDS AND USES FOR THE SAME | IMARX PHARMACEUTICAL CORP. (US) | 2000-09-27 | — | — | EP | claimed |
| US-6123923-A | ADMINISTERING A PATIENT A CONTRAST AGENT CONTAINING A STABILIZER, A PHOTOACTIVE AGENT, A GASEOUS PRECURSOR SUCH AS PERFLUORINATED COMPOUND OR GAS OR BOTH, AND SCANNING THE PATIENT USING ULTRASOUND IMAGING AND OPTICAL IMAGING | IMARX PHARMACEUTICAL CORP. (US) | 2000-09-26 | — | — | US | claimed |
| US-6120751-A | CONTRAST AGENT | IMARX PHARMACEUTICAL CORP. (US) | 2000-09-19 | — | — | US | claimed |
| WO-1999030620-A1 | OPTOACOUSTIC CONTRAST AGENTS AND METHODS FOR THEIR USE | IMARX PHARMACEUTICAL CORP. (US) | 1999-06-24 | — | — | WO | claimed |
| EP-0901793-A1 | Thermal preactivation of gaseous precursor filled compositions | IMARX PHARMACEUTICAL CORP. (US) | 1999-03-17 | — | — | EP | claimed |
| WO-1998042383-A1 | CHARGED LIPIDS AND USES FOR THE SAME | IMARX PHARMACEUTICAL CORP. (US) | 1998-10-01 | — | — | WO | claimed |